Litcius/Paper detail

Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects

Xuejun He, Gege Liu, Xinyan Chen, Yaqin Wang, Ran Liu, Changmao Wang, Yunzhe Huang, Jie Shen, Yuanwei Jia

2023Clinical Therapeutics17 citationsDOI

Topics & Concepts

CmaxMedicineWarfarinPharmacokineticsPharmacodynamicsPharmacologyInternal medicineAtrial fibrillationDiabetes Treatment and ManagementPotassium and Related DisordersPancreatic function and diabetes
Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects | Litcius